EMAIL THIS PAGE TO A FRIEND

Plastic and reconstructive surgery

Blindness caused by cosmetic filler injection: a review of cause and therapy.


PMID 25415089

Abstract

Vascular occlusion causing blindness is a rare yet greatly feared complication of the use of facial aesthetic fillers. The authors performed a review of the aesthetic literature to ascertain the reported cases of blindness and the literature reporting variations in the vascular anatomy of the human face. The authors suggest a small but potentially helpful addition to the accepted management of the acute case. Cases of blindness, mostly irreversible, from aesthetic filler injections have been reported from Asia, Europe, and North America. Autologous fat appears to be the most frequent filler causing blindness. Some cases of partial visual recovery have been reported with hyaluronic acid and calcium hydroxylapatite fillers. The sudden profusion of new medical and nonmedical aesthetic filler injectors raises a new cause for alarm about patient safety. The published reports in the medical literature are made by experienced aesthetic surgeons and thus the actual incidence may be even higher. Also, newer injectors may not be aware of the variations in the pattern of facial vascular arborization. The authors present a summary of the relevant literature to date and a suggested helpful addition to the protocols for urgent management.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

H7630
Hyaluronic acid sodium salt from bovine vitreous humor
H5388
Hyaluronic acid sodium salt from rooster comb, avian glycosaminoglycan polysaccharide
53747
Hyaluronic acid sodium salt from Streptococcus equi, bacterial glycosaminoglycan polysaccharide
49775
Hyaluronic acid sodium salt from Streptococcus equi, mol wt 1,200
40583
Hyaluronic acid sodium salt from Streptococcus equi, mol wt 8,000-15,000
94137
Hyaluronic acid sodium salt from Streptococcus equi, mol wt 10,000-30,000
97616
Hyaluronic acid sodium salt from Streptococcus equi, mol wt 15,000-30,000
42686
Hyaluronic acid sodium salt from Streptococcus equi, mol wt 30,000-50,000
08185
Hyaluronic acid sodium salt from Streptococcus equi, mol wt 50,000-70,000
75048
Hyaluronic acid sodium salt from Streptococcus equi, mol wt 70,000-90,000
96144
Hyaluronic acid sodium salt from Streptococcus equi, mol wt 70,000-120,000
75046
Hyaluronic acid sodium salt from Streptococcus equi, mol wt 90,000-110,000
06742
Hyaluronic acid sodium salt from Streptococcus equi, mol wt 120,000-350,000
75043
Hyaluronic acid sodium salt from Streptococcus equi, mol wt 130,000-150,000
75044
Hyaluronic acid sodium salt from Streptococcus equi, mol wt 150,000-300,000
00941
Hyaluronic acid sodium salt from Streptococcus equi, mol wt 300,000-500,000
75574
Hyaluronic acid sodium salt from Streptococcus equi, mol wt 500,000-750,000
53163
Hyaluronic acid sodium salt from Streptococcus equi, mol wt 750,000-1,000,000
41897
Hyaluronic acid sodium salt from Streptococcus equi, mol wt 1,000,000-1,250,000
80486
Hyaluronic acid sodium salt from Streptococcus equi, mol wt 1,250,000-1,500,000
63357
Hyaluronic acid sodium salt from Streptococcus equi, mol wt 1,500,000-1,750,000
02737
Hyaluronic acid sodium salt from Streptococcus equi, mol wt 1,750,000-2,000,000
51967
Hyaluronic acid sodium salt from Streptococcus equi, mol wt 2,000,000-2,200,000
73641
Hyaluronic acid sodium salt from Streptococcus equi, mol wt 2,000,000-2,400,000
H9390
Hyaluronic acid sodium salt from Streptococcus zooepidemicus, bacterial glycosaminoglycan polysaccharide